BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15965274)

  • 21. Neoplastic meningitis: a retrospective review of clinical presentations, radiological and cerebrospinal fluid findings.
    Jearanaisilp S; Sangruji T; Danchaivijitr C; Danchaivijitr N
    J Med Assoc Thai; 2014 Aug; 97(8):870-7. PubMed ID: 25345264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal Fluid Dissemination and Neoplastic Meningitis in Primary Brain Tumors.
    Chowdhary S; Damlo S; Chamberlain MC
    Cancer Control; 2017 Jan; 24(1):S1-S16. PubMed ID: 28557973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Value of tumor markers in the cerebrospinal fluid in the diagnosis of meningeal carcinomatosis].
    Shi Q; Pu CQ; Wu WP; Huang XS; Yu SY; Tian CL; Huang DH; Zhang JT
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1192-4. PubMed ID: 20501426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LDH isoenzymes in cerebrospinal fluid in various brain tumours.
    Lampl Y; Paniri Y; Eshel Y; Sarova-Pinhas I
    J Neurol Neurosurg Psychiatry; 1990 Aug; 53(8):697-9. PubMed ID: 2213048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis.
    Zhang Z; Tian C; Shi Q; Hao J; Zhao N; Liu Z
    Dis Markers; 2017; 2017():2467870. PubMed ID: 28298807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unusual presentation of carcinomatous meningitis: case report and review of typical CSF findings.
    Zeller JA; Zunker P; Witt K; Schlueter E; Deuschl G
    Neurol Res; 2002 Oct; 24(7):652-4. PubMed ID: 12392200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alkaline phosphatase level in CSF in various brain tumors and pulmonary carcinomatous meningitis.
    Lampl Y; Paniri Y; Eshel Y; Sarova-Pinchas I
    J Neurooncol; 1990 Aug; 9(1):35-40. PubMed ID: 2213114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.
    Lee JS; Melisko ME; Magbanua MJ; Kablanian AT; Scott JH; Rugo HS; Park JW
    Breast Cancer Res Treat; 2015 Nov; 154(2):339-49. PubMed ID: 26520840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinomatous meningitis in solid tumours.
    Jayson GC; Howell A
    Ann Oncol; 1996 Oct; 7(8):773-86. PubMed ID: 8922190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [On carcinomatous meningitis secondary to breast cancer].
    Mercier B
    Presse Med; 2000 Jun; 29(20):1133. PubMed ID: 10901795
    [No Abstract]   [Full Text] [Related]  

  • 31. NF-kappaB activation in cerebrospinal fluid cells from patients with meningitis.
    Ichiyama T; Isumi H; Yoshitomi T; Nishikawa M; Matsubara T; Furukawa S
    Neurol Res; 2002 Oct; 24(7):709-12. PubMed ID: 12392210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variations in tumor marker levels in metastatic breast cancer patients according to tumor subtypes.
    Kos T; Aksoy S; Sendur MA; Arik Z; Civelek B; Kandemir N; Ozdemir NY; Zengin N; Altundag K
    J BUON; 2013; 18(3):608-13. PubMed ID: 24065471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of epithelial growth factor receptor mutations in cerebrospinal fluid from patients with lung adenocarcinoma suspected of neoplastic meningitis.
    Shingyoji M; Kageyama H; Sakaida T; Nakajima T; Matsui Y; Itakura M; Iuchi T; Yokoi S; Kimura H; Iizasa T
    J Thorac Oncol; 2011 Jul; 6(7):1215-20. PubMed ID: 21610522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment.
    Bartsch R; Wenzel C; Pluschnig U; Hussian D; Sevelda U; Altorjai G; Locker GJ; Mader R; Zielinski CC; Steger GG
    BMC Cancer; 2006 Mar; 6():81. PubMed ID: 16563172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoplastic meningitis.
    Chamberlain MC
    Oncologist; 2008 Sep; 13(9):967-77. PubMed ID: 18776058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CSF carcinoembryonic antigen in meningeal carcinomatosis from breast cancer.
    Yap BS; Yap HY; Fritsche HA; Blumenschein G; Bodey GP
    JAMA; 1980 Oct; 244(14):1601-3. PubMed ID: 7420663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Axillary lymph node metastasis: CA-15-3 and carcinoembryonic antigen concentrations in fine-needle aspirates for preoperative diagnosis in patients with breast cancer.
    Kim MJ; Park BW; Lim JB; Kim HS; Kwak JY; Kim SJ; Park SH; Sohn YM; Moon HJ; Kim EK
    Radiology; 2010 Mar; 254(3):691-7. PubMed ID: 20123899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lactate dehydrogenase as a prognostic marker in neoplastic meningitis.
    Cacho-Díaz B; Lorenzana-Mendoza NA; Reyes-Soto G; Hernández-Estrada A; Monroy-Sosa A; Guraieb-Chahin P; Cantu-de-León D
    J Clin Neurosci; 2018 May; 51():39-42. PubMed ID: 29483012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Carcinomatous meningitis from prostate cancer diagnosed by cerebrospinal fluid cytology and magnetic resonance image: a case report and review of the literature].
    Yasufuku T; Shigemura K; Tanaka H; Matsumoto O; Nakano Y; Tanaka K; Fujisawa M
    Hinyokika Kiyo; 2009 Jun; 55(6):361-5. PubMed ID: 19588872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.